Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 14, 2009; 15(6): 727-731
Published online Feb 14, 2009. doi: 10.3748/wjg.15.727
Published online Feb 14, 2009. doi: 10.3748/wjg.15.727
Type of drug | Drug name | Doses (/day) | Number of patients |
None | 34 | ||
PPIs | 8 | ||
Rabeprazole sodium | 10 mg | 3 | |
Lansoprazole | 30 mg | 2 | |
Lansoprazole | 15 mg | 1 | |
Omeprazole | 20 mg | 2 | |
H2RAs | 16 | ||
Famotidine | 40 mg | 1 | |
Famotidine | 20 mg | 8 | |
Famotidine | 10 mg | 1 | |
Lafutidine | 20 mg | 2 | |
Nizatidine | 300 mg | 2 | |
Ranitidine hydrochloride | 75 mg | 1 | |
Cimetidine | 100 mg | 1 | |
Cytoprotective anti-ulcer drugs | 10 | ||
Rebamipide | 300 mg | 2 | |
Rebamipide | 200 mg | 1 | |
Rebamipide | 100 mg | 1 | |
Azulensulfonate sidium + L-Glutamine | 2 g | 2 | |
Teprenone | 1.5 g | 1 | |
Polaprezinc | 150 mg | 1 | |
Sofalcone | 300 mg | 1 | |
Alginate sodium | 180 mL | 1 |
- Citation: Nakashima S, Ota S, Arai S, Yoshino K, Inao M, Ishikawa K, Nakayama N, Imai Y, Nagoshi S, Mochida S. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin. World J Gastroenterol 2009; 15(6): 727-731
- URL: https://www.wjgnet.com/1007-9327/full/v15/i6/727.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.727